What are the three components of stroke that are taken into account with the Oxfordshire Classification of Stroke?
Give the Oxfordshire Classification of Stroke: 1. Hypertensive 66M presenting with homonymous hemianopia with ipsilateral ataxia?2. 72F with left sided weakness and dressing apraxia? Both with hypodensities on CT
2. PACI
What are the 5 different TOAST classifications?
What is the classification for a patient who presents with right sided weakness that on workup shows a >50% stenosis of the left ICA?
LAA
Give the ABCD score of the patient: 50 years oldBP of 140/90 Presented with broca's aphasia Lasting for 10 minutes No diabetes
0+0+1+1+1 = 3
No admission needed: 2 day stroke risk is 1%
Age ≥60 years 1 Blood pressure elevation (systolic >140 mmHg and/or diastolic ≥90 mmHg) 1 Clinical features Unilateral weakness 2 Speech disturbance without weakness 1 Duration of symptoms ≥60 minutes 2 10-59 minutes 1 Diabetes mellitus 1
Give the ABCD score of the patient:70 years oldBP of 141/90Presented with right sided plegiaLasting for 2 hoursWith DM
1+1+2+2+1= 7
ADMIT the patient
Score 1-3 (low)2 day risk = 1.0%7 day risk = 1.2%
Score 4-5 (moderate)2 day risk = 4.1%7 day risk = 5.9%
Score 6–7 (high)2 day risk = 8.1%7 day risk = 11.7%
How long should one wait prior to the starting of anti-platelet in a patient who underwent thrombolysis?
24 hours
What percentage of obstruction in the carotid UTZ necessitates referral to a neurosurgeon?
70%
Which among the 2 big ASA trials compared aspirin against ASA only, Heparin, ASA + Heparin and Placebo?
International Stroke Trial
The CAST (Chinese acute stroke trial) only compared against placebo VS ASA 160mg)
What antiplatelet was proved to be non-inferior to aspirin? (CAIST trial)
Cilostazol in Acute Ischemic Stroke
In the CAIST trial what was the NIHSS of the patient included? How about in the CHANCE trial?
CAIST: <15
CHANCE: 3 or less
Match the following neuroprotection agents with their trials:
A. CHIMES
B. ICTUS
C. CASTA
1C
2B
3A
In what subgroups is citicoline shown to have some possible benefit according to the ICTUS trial?
> 70 years old
<14 NIHSS
Patients NOT treated with rtPA
What laboratory values of the following would discourage the use of rTPA? PLT PT INR BP CBG
PLT <100,000 PT >15sa PTT>40s INR >1.7 BP >=185/110 CBG <50 >400
What is the period after the following events during which thrombolysis is discouraged?
How should BP be monitored during thrombolysis?
Q15 first 2 hours
Q30 next 6 hours
Q1 for 16 hours
What are the 4 relative exclusion criteria to thrombolyse within the 3-4.5 hour criteria? (This is based on the old ischemic stroke guidelines NOT the 2018 AHA)
In the National Institute of Neurological Disorders and Stroke t-PA trial 1. what is the primary outcome result in terms of disability at 3 months2.what is the primary outcome result in terms of mortality at 3 months3. what is the rate of sICH
What dosage was used in the J-ACT trial using alteplase for thrombolysis?
0.6mg per kg
Which ECASS (European Australasian Cooperative Acute Stroke Study) trial showed improved outcomes with thrombolysed patients?
ECASS 3. The first two used up to 6 hours window period for giving of rtpa while the 3rd used 4.5 hours
In IST 3, what was the golden period used? Did it improve the Oxford Handicap Score (OHS) of 0–2 at 6 months of the patients?
<6 hours. BUT not enough power to say that there is enough evidence to thrombolyse at 4.5-6 hours
Yes it did!
What factor of the STATE criteria does this man meet?NIHSS 21 with plegic right
12 hours post ictus
ASPECTS 3
Previously working as a secretary
Score >20 if dominant lobe >15 if non dominant Timing <48 hours Age <60 years Territory >50% MCA territory Expectation reasonable 5/5!
According to the Antiplatelet Trialists Collaboration taking ASA can have a _____% odds reduction for the composite outcome of MI, stroke or vascular death.
23
Identify which antiplatelet is studied in the following: